0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Pharmaceuticals Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27U6928
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Veterinary Pharmaceuticals Market Insights Forecast to 2028
BUY CHAPTERS

Global Veterinary Pharmaceuticals Market Research Report 2025

Code: QYRE-Auto-27U6928
Report
September 2025
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Pharmaceuticals Market Size

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%.

Veterinary Pharmaceuticals Market

Veterinary Pharmaceuticals Market

The global market for Veterinary Pharmaceuticals was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 143%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Pharmaceuticals.
The Veterinary Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Pharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Pharmaceuticals Market Report

Report Metric Details
Report Name Veterinary Pharmaceuticals Market
Accounted market size in 2022 $ 261 billion
Base Year 2022
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis(Pfizer), MERIAL, Merial, Lilly, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, CAHIC, Ringpu, Dahuanong, TECON, BIOK, Lukang Pharma, JINYU Group, China Animal Healthcare, Jiangxi Yiling, JIZHONG Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Veterinary Pharmaceuticals Market report?

Ans: The main players in the Veterinary Pharmaceuticals Market are Zoetis(Pfizer), MERIAL, Merial, Lilly, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, CAHIC, Ringpu, Dahuanong, TECON, BIOK, Lukang Pharma, JINYU Group, China Animal Healthcare, Jiangxi Yiling, JIZHONG Pharmaceutical

What are the Application segmentation covered in the Veterinary Pharmaceuticals Market report?

Ans: The Applications covered in the Veterinary Pharmaceuticals Market report are Poultry, Pets, Other

What are the Type segmentation covered in the Veterinary Pharmaceuticals Market report?

Ans: The Types covered in the Veterinary Pharmaceuticals Market report are Veterinary Biological Drugs, Veterinary Preparations, Others

Recommended Reports

Veterinary Equipment

Animal Health

Veterinary Vaccines

1 Veterinary Pharmaceuticals Market Overview
1.1 Product Definition
1.2 Veterinary Pharmaceuticals by Type
1.2.1 Global Veterinary Pharmaceuticals Market Value Comparison by Type (2024 VS 2031)
1.2.2 Veterinary Biological Drugs
1.2.3 Veterinary Preparations
1.2.4 Others
1.3 Veterinary Pharmaceuticals by Application
1.3.1 Global Veterinary Pharmaceuticals Market Value by Application (2024 VS 2031)
1.3.2 Poultry
1.3.3 Pets
1.3.4 Other
1.4 Global Veterinary Pharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Veterinary Pharmaceuticals Revenue 2020-2031
1.4.2 Global Veterinary Pharmaceuticals Sales 2020-2031
1.4.3 Global Veterinary Pharmaceuticals Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary Pharmaceuticals Market Competition by Manufacturers
2.1 Global Veterinary Pharmaceuticals Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Pharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary Pharmaceuticals Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary Pharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Pharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Pharmaceuticals, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Pharmaceuticals, Date of Enter into This Industry
2.8 Global Veterinary Pharmaceuticals Market Competitive Situation and Trends
2.8.1 Global Veterinary Pharmaceuticals Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Pharmaceuticals Players Market Share by Revenue
2.8.3 Global Veterinary Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Pharmaceuticals Market Scenario by Region
3.1 Global Veterinary Pharmaceuticals Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary Pharmaceuticals Sales by Region: 2020-2031
3.2.1 Global Veterinary Pharmaceuticals Sales by Region: 2020-2025
3.2.2 Global Veterinary Pharmaceuticals Sales by Region: 2026-2031
3.3 Global Veterinary Pharmaceuticals Revenue by Region: 2020-2031
3.3.1 Global Veterinary Pharmaceuticals Revenue by Region: 2020-2025
3.3.2 Global Veterinary Pharmaceuticals Revenue by Region: 2026-2031
3.4 North America Veterinary Pharmaceuticals Market Facts & Figures by Country
3.4.1 North America Veterinary Pharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary Pharmaceuticals Sales by Country (2020-2031)
3.4.3 North America Veterinary Pharmaceuticals Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Pharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Veterinary Pharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary Pharmaceuticals Sales by Country (2020-2031)
3.5.3 Europe Veterinary Pharmaceuticals Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Pharmaceuticals Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Pharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary Pharmaceuticals Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary Pharmaceuticals Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary Pharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Veterinary Pharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary Pharmaceuticals Sales by Country (2020-2031)
3.7.3 Latin America Veterinary Pharmaceuticals Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Pharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Pharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary Pharmaceuticals Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary Pharmaceuticals Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Pharmaceuticals Sales by Type (2020-2031)
4.1.1 Global Veterinary Pharmaceuticals Sales by Type (2020-2025)
4.1.2 Global Veterinary Pharmaceuticals Sales by Type (2026-2031)
4.1.3 Global Veterinary Pharmaceuticals Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Pharmaceuticals Revenue by Type (2020-2031)
4.2.1 Global Veterinary Pharmaceuticals Revenue by Type (2020-2025)
4.2.2 Global Veterinary Pharmaceuticals Revenue by Type (2026-2031)
4.2.3 Global Veterinary Pharmaceuticals Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary Pharmaceuticals Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary Pharmaceuticals Sales by Application (2020-2031)
5.1.1 Global Veterinary Pharmaceuticals Sales by Application (2020-2025)
5.1.2 Global Veterinary Pharmaceuticals Sales by Application (2026-2031)
5.1.3 Global Veterinary Pharmaceuticals Sales Market Share by Application (2020-2031)
5.2 Global Veterinary Pharmaceuticals Revenue by Application (2020-2031)
5.2.1 Global Veterinary Pharmaceuticals Revenue by Application (2020-2025)
5.2.2 Global Veterinary Pharmaceuticals Revenue by Application (2026-2031)
5.2.3 Global Veterinary Pharmaceuticals Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary Pharmaceuticals Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis(Pfizer)
6.1.1 Zoetis(Pfizer) Company Information
6.1.2 Zoetis(Pfizer) Description and Business Overview
6.1.3 Zoetis(Pfizer) Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis(Pfizer) Veterinary Pharmaceuticals Product Portfolio
6.1.5 Zoetis(Pfizer) Recent Developments/Updates
6.2 MERIAL
6.2.1 MERIAL Company Information
6.2.2 MERIAL Description and Business Overview
6.2.3 MERIAL Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.2.4 MERIAL Veterinary Pharmaceuticals Product Portfolio
6.2.5 MERIAL Recent Developments/Updates
6.3 Merial
6.3.1 Merial Company Information
6.3.2 Merial Description and Business Overview
6.3.3 Merial Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merial Veterinary Pharmaceuticals Product Portfolio
6.3.5 Merial Recent Developments/Updates
6.4 Lilly
6.4.1 Lilly Company Information
6.4.2 Lilly Description and Business Overview
6.4.3 Lilly Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lilly Veterinary Pharmaceuticals Product Portfolio
6.4.5 Lilly Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Veterinary Pharmaceuticals Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Boehringer
6.6.1 Boehringer Company Information
6.6.2 Boehringer Description and Business Overview
6.6.3 Boehringer Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boehringer Veterinary Pharmaceuticals Product Portfolio
6.6.5 Boehringer Recent Developments/Updates
6.7 Novartis
6.7.1 Novartis Company Information
6.7.2 Novartis Description and Business Overview
6.7.3 Novartis Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novartis Veterinary Pharmaceuticals Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Virbac
6.8.1 Virbac Company Information
6.8.2 Virbac Description and Business Overview
6.8.3 Virbac Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Virbac Veterinary Pharmaceuticals Product Portfolio
6.8.5 Virbac Recent Developments/Updates
6.9 Ceva
6.9.1 Ceva Company Information
6.9.2 Ceva Description and Business Overview
6.9.3 Ceva Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ceva Veterinary Pharmaceuticals Product Portfolio
6.9.5 Ceva Recent Developments/Updates
6.10 Vetoquinol
6.10.1 Vetoquinol Company Information
6.10.2 Vetoquinol Description and Business Overview
6.10.3 Vetoquinol Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Vetoquinol Veterinary Pharmaceuticals Product Portfolio
6.10.5 Vetoquinol Recent Developments/Updates
6.11 CAHIC
6.11.1 CAHIC Company Information
6.11.2 CAHIC Description and Business Overview
6.11.3 CAHIC Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CAHIC Veterinary Pharmaceuticals Product Portfolio
6.11.5 CAHIC Recent Developments/Updates
6.12 Ringpu
6.12.1 Ringpu Company Information
6.12.2 Ringpu Description and Business Overview
6.12.3 Ringpu Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ringpu Veterinary Pharmaceuticals Product Portfolio
6.12.5 Ringpu Recent Developments/Updates
6.13 Dahuanong
6.13.1 Dahuanong Company Information
6.13.2 Dahuanong Description and Business Overview
6.13.3 Dahuanong Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Dahuanong Veterinary Pharmaceuticals Product Portfolio
6.13.5 Dahuanong Recent Developments/Updates
6.14 TECON
6.14.1 TECON Company Information
6.14.2 TECON Description and Business Overview
6.14.3 TECON Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.14.4 TECON Veterinary Pharmaceuticals Product Portfolio
6.14.5 TECON Recent Developments/Updates
6.15 BIOK
6.15.1 BIOK Company Information
6.15.2 BIOK Description and Business Overview
6.15.3 BIOK Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.15.4 BIOK Veterinary Pharmaceuticals Product Portfolio
6.15.5 BIOK Recent Developments/Updates
6.16 Lukang Pharma
6.16.1 Lukang Pharma Company Information
6.16.2 Lukang Pharma Description and Business Overview
6.16.3 Lukang Pharma Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Lukang Pharma Veterinary Pharmaceuticals Product Portfolio
6.16.5 Lukang Pharma Recent Developments/Updates
6.17 JINYU Group
6.17.1 JINYU Group Company Information
6.17.2 JINYU Group Description and Business Overview
6.17.3 JINYU Group Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.17.4 JINYU Group Veterinary Pharmaceuticals Product Portfolio
6.17.5 JINYU Group Recent Developments/Updates
6.18 China Animal Healthcare
6.18.1 China Animal Healthcare Company Information
6.18.2 China Animal Healthcare Description and Business Overview
6.18.3 China Animal Healthcare Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.18.4 China Animal Healthcare Veterinary Pharmaceuticals Product Portfolio
6.18.5 China Animal Healthcare Recent Developments/Updates
6.19 Jiangxi Yiling
6.19.1 Jiangxi Yiling Company Information
6.19.2 Jiangxi Yiling Description and Business Overview
6.19.3 Jiangxi Yiling Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Jiangxi Yiling Veterinary Pharmaceuticals Product Portfolio
6.19.5 Jiangxi Yiling Recent Developments/Updates
6.20 JIZHONG Pharmaceutical
6.20.1 JIZHONG Pharmaceutical Company Information
6.20.2 JIZHONG Pharmaceutical Description and Business Overview
6.20.3 JIZHONG Pharmaceutical Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.20.4 JIZHONG Pharmaceutical Veterinary Pharmaceuticals Product Portfolio
6.20.5 JIZHONG Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Pharmaceuticals Industry Chain Analysis
7.2 Veterinary Pharmaceuticals Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Pharmaceuticals Production Mode & Process Analysis
7.4 Veterinary Pharmaceuticals Sales and Marketing
7.4.1 Veterinary Pharmaceuticals Sales Channels
7.4.2 Veterinary Pharmaceuticals Distributors
7.5 Veterinary Pharmaceuticals Customer Analysis
8 Veterinary Pharmaceuticals Market Dynamics
8.1 Veterinary Pharmaceuticals Industry Trends
8.2 Veterinary Pharmaceuticals Market Drivers
8.3 Veterinary Pharmaceuticals Market Challenges
8.4 Veterinary Pharmaceuticals Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Veterinary Pharmaceuticals Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Veterinary Pharmaceuticals Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Veterinary Pharmaceuticals Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Veterinary Pharmaceuticals Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Veterinary Pharmaceuticals Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary Pharmaceuticals Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Veterinary Pharmaceuticals Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Veterinary Pharmaceuticals Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Veterinary Pharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Pharmaceuticals, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Pharmaceuticals, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Pharmaceuticals, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Pharmaceuticals as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Pharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Veterinary Pharmaceuticals Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Veterinary Pharmaceuticals Sales Market Share by Region (2020-2025)
 Table 19. Global Veterinary Pharmaceuticals Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Veterinary Pharmaceuticals Sales Market Share by Region (2026-2031)
 Table 21. Global Veterinary Pharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Veterinary Pharmaceuticals Revenue Market Share by Region (2020-2025)
 Table 23. Global Veterinary Pharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Veterinary Pharmaceuticals Revenue Market Share by Region (2026-2031)
 Table 25. North America Veterinary Pharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Veterinary Pharmaceuticals Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Veterinary Pharmaceuticals Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Veterinary Pharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Veterinary Pharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Veterinary Pharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Veterinary Pharmaceuticals Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Veterinary Pharmaceuticals Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Veterinary Pharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Veterinary Pharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Veterinary Pharmaceuticals Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Veterinary Pharmaceuticals Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Veterinary Pharmaceuticals Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Veterinary Pharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Veterinary Pharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Veterinary Pharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Veterinary Pharmaceuticals Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Veterinary Pharmaceuticals Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Veterinary Pharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Veterinary Pharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Veterinary Pharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Veterinary Pharmaceuticals Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Veterinary Pharmaceuticals Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Veterinary Pharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Pharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Veterinary Pharmaceuticals Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Veterinary Pharmaceuticals Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Veterinary Pharmaceuticals Sales Market Share by Type (2020-2025)
 Table 53. Global Veterinary Pharmaceuticals Sales Market Share by Type (2026-2031)
 Table 54. Global Veterinary Pharmaceuticals Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Veterinary Pharmaceuticals Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Veterinary Pharmaceuticals Revenue Market Share by Type (2020-2025)
 Table 57. Global Veterinary Pharmaceuticals Revenue Market Share by Type (2026-2031)
 Table 58. Global Veterinary Pharmaceuticals Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Veterinary Pharmaceuticals Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Veterinary Pharmaceuticals Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Veterinary Pharmaceuticals Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Veterinary Pharmaceuticals Sales Market Share by Application (2020-2025)
 Table 63. Global Veterinary Pharmaceuticals Sales Market Share by Application (2026-2031)
 Table 64. Global Veterinary Pharmaceuticals Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Veterinary Pharmaceuticals Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Veterinary Pharmaceuticals Revenue Market Share by Application (2020-2025)
 Table 67. Global Veterinary Pharmaceuticals Revenue Market Share by Application (2026-2031)
 Table 68. Global Veterinary Pharmaceuticals Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Veterinary Pharmaceuticals Price (USD/Pcs) by Application (2026-2031)
 Table 70. Zoetis(Pfizer) Company Information
 Table 71. Zoetis(Pfizer) Description and Business Overview
 Table 72. Zoetis(Pfizer) Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Zoetis(Pfizer) Veterinary Pharmaceuticals Product
 Table 74. Zoetis(Pfizer) Recent Developments/Updates
 Table 75. MERIAL Company Information
 Table 76. MERIAL Description and Business Overview
 Table 77. MERIAL Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. MERIAL Veterinary Pharmaceuticals Product
 Table 79. MERIAL Recent Developments/Updates
 Table 80. Merial Company Information
 Table 81. Merial Description and Business Overview
 Table 82. Merial Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Merial Veterinary Pharmaceuticals Product
 Table 84. Merial Recent Developments/Updates
 Table 85. Lilly Company Information
 Table 86. Lilly Description and Business Overview
 Table 87. Lilly Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Lilly Veterinary Pharmaceuticals Product
 Table 89. Lilly Recent Developments/Updates
 Table 90. Bayer Company Information
 Table 91. Bayer Description and Business Overview
 Table 92. Bayer Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Bayer Veterinary Pharmaceuticals Product
 Table 94. Bayer Recent Developments/Updates
 Table 95. Boehringer Company Information
 Table 96. Boehringer Description and Business Overview
 Table 97. Boehringer Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Boehringer Veterinary Pharmaceuticals Product
 Table 99. Boehringer Recent Developments/Updates
 Table 100. Novartis Company Information
 Table 101. Novartis Description and Business Overview
 Table 102. Novartis Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Novartis Veterinary Pharmaceuticals Product
 Table 104. Novartis Recent Developments/Updates
 Table 105. Virbac Company Information
 Table 106. Virbac Description and Business Overview
 Table 107. Virbac Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Virbac Veterinary Pharmaceuticals Product
 Table 109. Virbac Recent Developments/Updates
 Table 110. Ceva Company Information
 Table 111. Ceva Description and Business Overview
 Table 112. Ceva Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Ceva Veterinary Pharmaceuticals Product
 Table 114. Ceva Recent Developments/Updates
 Table 115. Vetoquinol Company Information
 Table 116. Vetoquinol Description and Business Overview
 Table 117. Vetoquinol Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Vetoquinol Veterinary Pharmaceuticals Product
 Table 119. Vetoquinol Recent Developments/Updates
 Table 120. CAHIC Company Information
 Table 121. CAHIC Description and Business Overview
 Table 122. CAHIC Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. CAHIC Veterinary Pharmaceuticals Product
 Table 124. CAHIC Recent Developments/Updates
 Table 125. Ringpu Company Information
 Table 126. Ringpu Description and Business Overview
 Table 127. Ringpu Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Ringpu Veterinary Pharmaceuticals Product
 Table 129. Ringpu Recent Developments/Updates
 Table 130. Dahuanong Company Information
 Table 131. Dahuanong Description and Business Overview
 Table 132. Dahuanong Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Dahuanong Veterinary Pharmaceuticals Product
 Table 134. Dahuanong Recent Developments/Updates
 Table 135. TECON Company Information
 Table 136. TECON Description and Business Overview
 Table 137. TECON Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. TECON Veterinary Pharmaceuticals Product
 Table 139. TECON Recent Developments/Updates
 Table 140. BIOK Company Information
 Table 141. BIOK Description and Business Overview
 Table 142. BIOK Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. BIOK Veterinary Pharmaceuticals Product
 Table 144. BIOK Recent Developments/Updates
 Table 145. Lukang Pharma Company Information
 Table 146. Lukang Pharma Description and Business Overview
 Table 147. Lukang Pharma Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 148. Lukang Pharma Veterinary Pharmaceuticals Product
 Table 149. Lukang Pharma Recent Developments/Updates
 Table 150. JINYU Group Company Information
 Table 151. JINYU Group Description and Business Overview
 Table 152. JINYU Group Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 153. JINYU Group Veterinary Pharmaceuticals Product
 Table 154. JINYU Group Recent Developments/Updates
 Table 155. China Animal Healthcare Company Information
 Table 156. China Animal Healthcare Description and Business Overview
 Table 157. China Animal Healthcare Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 158. China Animal Healthcare Veterinary Pharmaceuticals Product
 Table 159. China Animal Healthcare Recent Developments/Updates
 Table 160. Jiangxi Yiling Company Information
 Table 161. Jiangxi Yiling Description and Business Overview
 Table 162. Jiangxi Yiling Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 163. Jiangxi Yiling Veterinary Pharmaceuticals Product
 Table 164. Jiangxi Yiling Recent Developments/Updates
 Table 165. JIZHONG Pharmaceutical Company Information
 Table 166. JIZHONG Pharmaceutical Description and Business Overview
 Table 167. JIZHONG Pharmaceutical Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 168. JIZHONG Pharmaceutical Veterinary Pharmaceuticals Product
 Table 169. JIZHONG Pharmaceutical Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Veterinary Pharmaceuticals Distributors List
 Table 173. Veterinary Pharmaceuticals Customers List
 Table 174. Veterinary Pharmaceuticals Market Trends
 Table 175. Veterinary Pharmaceuticals Market Drivers
 Table 176. Veterinary Pharmaceuticals Market Challenges
 Table 177. Veterinary Pharmaceuticals Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Pharmaceuticals
 Figure 2. Global Veterinary Pharmaceuticals Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Veterinary Pharmaceuticals Market Share by Type: 2024 & 2031
 Figure 4. Veterinary Biological Drugs Product Picture
 Figure 5. Veterinary Preparations Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Veterinary Pharmaceuticals Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Veterinary Pharmaceuticals Market Share by Application: 2024 & 2031
 Figure 9. Poultry
 Figure 10. Pets
 Figure 11. Other
 Figure 12. Global Veterinary Pharmaceuticals Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Veterinary Pharmaceuticals Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Veterinary Pharmaceuticals Sales (2020-2031) & (K Pcs)
 Figure 15. Global Veterinary Pharmaceuticals Average Price (USD/Pcs) & (2020-2031)
 Figure 16. Veterinary Pharmaceuticals Report Years Considered
 Figure 17. Veterinary Pharmaceuticals Sales Share by Manufacturers in 2024
 Figure 18. Global Veterinary Pharmaceuticals Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Veterinary Pharmaceuticals Players: Market Share by Revenue in Veterinary Pharmaceuticals in 2024
 Figure 20. Veterinary Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Veterinary Pharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Veterinary Pharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 23. North America Veterinary Pharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Veterinary Pharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 27. Europe Veterinary Pharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Veterinary Pharmaceuticals Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Veterinary Pharmaceuticals Revenue Market Share by Region (2020-2031)
 Figure 35. China Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Veterinary Pharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Veterinary Pharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Veterinary Pharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Veterinary Pharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Veterinary Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Veterinary Pharmaceuticals by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Veterinary Pharmaceuticals by Type (2020-2031)
 Figure 57. Global Veterinary Pharmaceuticals Price (USD/Pcs) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Veterinary Pharmaceuticals by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Veterinary Pharmaceuticals by Application (2020-2031)
 Figure 60. Global Veterinary Pharmaceuticals Price (USD/Pcs) by Application (2020-2031)
 Figure 61. Veterinary Pharmaceuticals Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart